GTCR LLC
- SEC CIK
- 0001576350
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 13, 2026.SEC
- Positions
- 5
- −1 vs. Q1 2026
- Total value
- $3.91B
- +$125.43M (+3.3%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| GPNGLOBAL PMTS INC COM | Stock | 43,268,041 | $3.14B | 80.36% | 00.0% | Unchanged | View |
| AJGGALLAGHER ARTHUR J & CO | COM | 2,373,773 | $544.95M | 13.95% | 00.0% | Unchanged | View |
| MRVIMARAVAI LIFESCIENCES HLDGS I | COM CL A | 20,150,005 | $125.74M | 3.22% | 00.0% | Unchanged | View |
| GOGOGOGO INC | COM | 23,239,011 | $72.04M | 1.84% | 00.0% | Unchanged | View |
| SEATVIVID SEATS INC | COM CL A | 3,768,633 | $24.57M | 0.63% | 00.0% | Unchanged | View |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are no longer in this filing.
| Security | Class | Shares, Q1 2026 | Value, Q1 2026 | % of portfolio, Q1 2026 |
|---|---|---|---|---|
| SHCSOTERA HEALTH CO | COM | 12,735,301 | $182.62M | 4.83% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | 5 | $3.91B | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 6 | $3.78B | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 4 | $602M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 13, 2025 | 3 | $905.77M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 3 | $936.98M | vs. Q1 2025 | SEC |
| Q1 2025 | May 14, 2025 | 3 | $891.97M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 3 | $1.04B | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 13, 2024 | 4 | $1.28B | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 13, 2024Amended | 4 | $1.2B | vs. Q1 2024 | SECSEC |
| Q1 2024 | May 14, 2024 | 3 | $1.18B | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 3 | $1.65B | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 13, 2023 | 3 | $1.65B | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 11, 2023 | 3 | $2.13B | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 3 | $2.02B | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 26, 2023 | 4 | $1.72B | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 15, 2022Amended | 4 | $1.69B | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 19, 2022 | 4 | $2.8B | vs. Q1 2022 | SEC |
| Q1 2022 | May 10, 2022 | 4 | $3.16B | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 4 | $3.28B | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 1, 2021 | 4 | $3.94B | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 5, 2021 | 4 | $3.59B | vs. Q1 2021 | SEC |
| Q1 2021 | May 17, 2021 | 5 | $3.54B | – | SEC |